Maraviroc Tablet, Film Coated
NDC Package 73141-024-02

The code 73141-024-02 identifies a specific commercial package of 60 tablet, film coated in 1 bottle of Maraviroc, a human prescription drug labeled by A2a Integrated Pharmaceuticals. This product is billed for "EA" each discreet unit and contains an estimated amount of 60 billable units per package. This tablet, film coated is formulated for oral use and contains maraviroc as the active substance.

Yes, this product is active and verified within the NDC Directory. It was introduced to the market by A2a Integrated Pharmaceuticals on May 16, 2024. The current certification is valid through December 31, 2026.

Maraviroc is used with other HIV medications to help control HIV infection. It helps to decrease the amount of HIV in your body so your immune system can work better. This lowers your chance of getting HIV complications (such as new infections, cancer) and improves your quality of life. Maraviroc belongs to a class of drugs known as entry inhibitors. It works by blocking the HIV virus from infecting healthy immune cells (T-cells). Maraviroc is not a cure for HIV infection. To decrease your risk of spreading HIV disease to others, do all of the following: (1) continue to take all HIV medications exactly as prescribed by your doctor, (2) always use an effective barrier method (latex or polyurethane condoms/dental dams) during all sexual activity, and (3) do not share personal items (such as needles/syringes, toothbrushes, and razors) that may have contacted blood or other body fluids. Consult your doctor or pharmacist for more details.

For medical billing and reimbursement, this package follows the 11-digit CMS format: 73141002402. Quantities are measured in per "each", products billed on a per each basis are usually products dispensed in discreet units.. There are 60 total billable units per package. The table below illustrates the segment conversion from the 10-digit labeler code to the 11-digit provider format.